NFE2L2 and Huntington disease: Various therapies have been adapted to counteract OS and inflammation in HD; in particular, the stimulation of the Nrf-2/ARE pathway has be proven to be efficacious, associated with increased expression of antioxidant enzymes and reduction of ROS levels in CNS [82].